Objectives: This study estimates the prevalence of allergic diseases in a group of Italian elite mountain bikers, compares the prevalence of infectious episodes between allergic and nonallergic athletes, and evaluates asthma and rhinitis symptom control in allergic athletes. Design: Two hundred twenty-six Italian nonsmoking mountain bikers received by mail the Allergy Questionnaire for Athletes (AQUA) and completed it. The RhinAsthma Patient Perspective (RAPP) questionnaire was sent to the 108 participants with a positive AQUA score and 104 returned the questionnaire. Methods: Athletes with an AQUA score $5 or,5 were defined AQUA+ (allergic) or AQUA2 (nonallergic), respectively. RhinAsthma Patient Perspective questionnaire total score $15 was indicative of a poor control of symptoms. Results: Of the 226 athletes, 47.8% were AQUA+, whereas 52.2% were AQUA2. A higher number of AQUA+ athletes reported frequent upper respiratory tract infections (URTIs) and herpes labialis than AQUA2 athletes (P, 0.001), and the prevalence of URTI was greater in the subgroup of AQUA+ athletes who trained $3 hours per session. According to RAPP questionnaire score, 21.1% of AQUA+ mountain bikers had a poor control of asthma and rhinitis symptoms. Conclusions: Our study shows a high prevalence of allergy among Italian elite mountain bikers whose asthma and rhinitis symptoms are poorly controlled in about a fifth of the sample. Allergic athletes, mainly those training more than 3 hours per session, are at higher risk of URTI and herpes labialis. Screening programs to detect allergic diseases and to evaluate symptom control in athletes should be strongly encouraged.
Evaluation of allergic diseases, symptom control, and relation to infections in a group of Italian elite mountain bikers / Perrotta, F.; Simeon, V.; Bonini, M.; Ferritto, L.; Arenare, L.; Nigro, E.; Nicolai, A.; Daniele, A.; Calabrese, C.. - In: CLINICAL JOURNAL OF SPORT MEDICINE. - ISSN 1050-642X. - 30:5(2020), pp. 465-469. [10.1097/JSM.0000000000000678]
Evaluation of allergic diseases, symptom control, and relation to infections in a group of Italian elite mountain bikers
Perrotta F.Primo
Writing – Original Draft Preparation
;Simeon V.;Bonini M.;Nigro E.;Nicolai A.;
2020
Abstract
Objectives: This study estimates the prevalence of allergic diseases in a group of Italian elite mountain bikers, compares the prevalence of infectious episodes between allergic and nonallergic athletes, and evaluates asthma and rhinitis symptom control in allergic athletes. Design: Two hundred twenty-six Italian nonsmoking mountain bikers received by mail the Allergy Questionnaire for Athletes (AQUA) and completed it. The RhinAsthma Patient Perspective (RAPP) questionnaire was sent to the 108 participants with a positive AQUA score and 104 returned the questionnaire. Methods: Athletes with an AQUA score $5 or,5 were defined AQUA+ (allergic) or AQUA2 (nonallergic), respectively. RhinAsthma Patient Perspective questionnaire total score $15 was indicative of a poor control of symptoms. Results: Of the 226 athletes, 47.8% were AQUA+, whereas 52.2% were AQUA2. A higher number of AQUA+ athletes reported frequent upper respiratory tract infections (URTIs) and herpes labialis than AQUA2 athletes (P, 0.001), and the prevalence of URTI was greater in the subgroup of AQUA+ athletes who trained $3 hours per session. According to RAPP questionnaire score, 21.1% of AQUA+ mountain bikers had a poor control of asthma and rhinitis symptoms. Conclusions: Our study shows a high prevalence of allergy among Italian elite mountain bikers whose asthma and rhinitis symptoms are poorly controlled in about a fifth of the sample. Allergic athletes, mainly those training more than 3 hours per session, are at higher risk of URTI and herpes labialis. Screening programs to detect allergic diseases and to evaluate symptom control in athletes should be strongly encouraged.File | Dimensione | Formato | |
---|---|---|---|
Perrotta_Evaluation_2020.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
301.03 kB
Formato
Adobe PDF
|
301.03 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.